Truly, the described clinical scenario1 had its origins in 1999 with the discovery and ongoing characterization of IL-18 binding protein (IL-18BP) by Novick et al.2 We are grateful for their correspondence detailing the salient properties of this molecule.3 Regrettably, our original article was unable to include such details due to space limitations and the need to provide sufficient detail on the clinical scenario presented. We obviously agree that this molecule is well suited to the task of therapeutically blocking IL-18.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qodmrq
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Cutaneous squamous cell carcinoma (cSCC) are amongst the most common cancers with metastatic potential. Specific clinical and pathological “...
-
A Vietnam War Timeline [Note: This timeline is an abbreviated version of the more detailed timeline posted on the Public Broadcasting System...
-
Copyright © 1999-2007 by , Kai Froeb. Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free ...
-
Greens Blue Flame supplies propane tank installation services and propane delivery in the Houston, TX area. We also offer bulk commercial de...
-
IZE is a professional association dedicated to expanding the educational impact of zoos and aquariums worldwide, to enhance the understandin...
-
BibMe Free Bibliography & Citation Maker - MLA, APA, Chicago, Harvard from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inor...
-
1,001 FREE cover letter examples and samples for consultants, career changers, and job hunters. The FIRST and BEST cover letters on the Inte...
-
Purpose. To assess the long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK) for moderate to high myopia. Methods...
-
The National Booster Club Training Council, Providing Guidance, Education, Training and Support from #AlexandrosSfakianakis via Alexandros...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου